statistiche ricercatore

Continente	#
EU - Europa	587
NA - Nord America	558
AS - Asia	193
SA - Sud America	12
Continente sconosciuto - Info sul continente non disponibili	2
AF - Africa	1
OC - Oceania	1
Totale	1.354

Nazione	#
US - Stati Uniti d'America	527
GB - Regno Unito	203
DE - Germania	99
IT - Italia	95
CN - Cina	86
SE - Svezia	69
CA - Canada	31
IN - India	28
SG - Singapore	27
UA - Ucraina	27
KR - Corea	18
FR - Francia	17
TR - Turchia	17
EU - Europa	14
IE - Irlanda	14
BE - Belgio	12
FI - Finlandia	12
RU - Federazione Russa	12
NL - Olanda	8
CO - Colombia	7
PL - Polonia	7
GR - Grecia	5
HK - Hong Kong	5
ID - Indonesia	5
JP - Giappone	3
BR - Brasile	2
DK - Danimarca	2
IR - Iran	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AR - Argentina	1
AT - Austria	1
AU - Australia	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CL - Cile	1
CZ - Repubblica Ceca	1
EE - Estonia	1
KH - Cambogia	1
RO - Romania	1
VE - Venezuela	1
Totale	1.367

Nome	#
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens	222
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir	219
In vitro efficacy of a non-conventional (folding) HIV-1 protease inhibitor without selection of resistance	184
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder (INR) HIV-1-infected patients treated with HAART	180
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses	169
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy	160
The non-conventional (folding) protease inhibitor blocks the human immunodeficiency virus type-1 replication without evidence of resistance during in vitro passage	144
Susceptibility to a non-conventional (folding) protease inhibitor of human immunodeficiency virus type 1 isolates in vitro	142
Totale	1.420

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	154	0	0	0	18	14	22	30	11	24	22	10	3
2020/2021	162	10	9	17	5	11	9	11	6	26	12	40	6
2021/2022	140	17	9	10	8	8	7	15	7	15	14	8	22
2022/2023	200	35	29	16	24	13	28	22	4	18	1	6	4
2023/2024	93	4	5	1	5	17	10	8	8	1	2	4	28
2024/2025	43	10	28	3	2	0	0	0	0	0	0	0	0
Totale													1.420

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca